News

New type of antivenom to reduce 100,000 fatalities each year from venomous snake bites being developed by Bristol scientists

A new approach of treating life-threatening snake bites responsible for around 100,000 deaths globally each year is being pioneered by an international research consortium led by University of Bristol scientists. The EU-funded ADDovenom study, involving teams in the UK, France, Belgium and Portugal, set out to create a new type of antivenom treatment to neutralise and eliminate venom toxins from the bloodstream with more efficacy, safety and affordability than what is available today.